B cell supernatants containing secreted antibodies were diluted in
H
2O,
4x sample loading buffer (Life Technologies) and
10x sample reducing agent(Life Technologies) and loaded onto precast gels with a
4-12% acrylamide gradient(Invitrogen). The
iBlot2 apparatus (Life Technologies) was used for protein transfer to
PVDF membranes followed by blocking for 1 h at room temperature with 3% BSA in TBS. The
membrane was incubated with different combinations of primary and secondary antibodies
diluted in TBS/1% BSA for 1 h at room temperature with 2 sequential TBS incubations to
wash the membrane between incubations. For detection of IgG, anti-human IgG-biotinylated
antibody (Southern Biotech, 2040-08) was used at 1 µg ml
-1, followed by
25 ng ml
-1 streptavidin-horseradish peroxidase (HRP) (Jackson ImmunoResearch,
016-030-084). IgM isotypes were stained with 10 µg ml
-1 unlabeled goat
anti-human IgM (Southern Biotech, 2020-01) and 8 ng ml
-1 donkey anti-goat HRP(Jackson ImmunoResearch, 705-036-147). To detect LAIR1-containing antibodies, a polyclonal
goat anti-human LAIR1 antibody (R&D) at 2 µg ml
-1 was combined
with secondary
donkey anti-goat HRP. Membranes were developed with ECL-substrate on a
Las4000 imager (General Electric Company).
Pieper K., Tan J., Piccoli L., Foglierini M., Barbieri S., Chen Y., Silacci-Fregni C., Wolf T., Jarrossay D., Anderle M., Abdi A., Ndungu F.M., Doumbo O.K., Traore B., Tran T.M., Jongo S., Zenklusen I., Crompton P.D., Daubenberger C., Bull P.C., Sallusto F, & Lanzavecchia A. (2017). Public antibodies to malaria antigens generated by two LAIR1 insertion modalities. Nature, 548(7669), 597-601.